Absci Corp (NASDAQ:ABSI) shares are trading lower by 9.4% to $4.46 Wednesday afternoon after the company announced an offering of 16.7 million shares at $4.50 per share.
The underwriters have an option to purchase an additional 2.505 million shares. The gross proceeds from the offering are expected to be approximately $75.2 million. Absci plans to utilize the net proceeds for the development of its internal asset programs, investment in its Integrated Drug Creation™ platform, including AI and wet-lab technologies and for general corporate purposes.
Morgan Stanley and TD Cowen are serving as joint book-running managers for the offering, which is anticipated to close around March 1, subject to customary closing conditions.
See Also: Bitcoin Crosses ...
ABSI) Shares Are Falling>Full story available on Benzinga.com